SEC 13F Intelligence

Ghost Tree Capital, LLC / 2655787D

Ghost Tree Capital, LLC’s Blueprint Medicines Position

Does Ghost Tree Capital, LLC own Blueprint Medicines (2655787D)? Yes — 140.0K shares worth $13M (+3.91% of its 13F portfolio) as of Q3 2024, up from 40.0K shares the prior filed quarter.

Position Value
$13M
Q3 2024
Shares
140.0K
% of Portfolio
+3.91%
Quarters Held
9
currently held

Position History 2655787D

Reported value by quarter
Q1 ’19: $19MQ1 ’19Q2 ’19: $35MQ3 ’19: $24MQ3 ’19Q4 ’19: $12MQ3 ’22: $4MQ3 ’22Q4 ’22: $876,000Q1 ’24: $7MQ1 ’24Q2 ’24: $4MQ3 ’24: $13MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024140.0K$13M+3.91%
Q2 202440.0K$4M+1.35%
Q1 202472.8K$7M+1.91%
Q4 202220.0K$876,000+0.37%
Q3 202265.0K$4M+1.20%
Q4 2019150.0K$12M+2.27%
Q3 2019325.0K$24M+6.07%
Q2 2019375.0K$35M+7.41%
Q1 2019240.0K$19M+5.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of 2655787D.